Last update 21 Nov 2024

VAL-1000

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
CDK
Mechanism
CDK inhibitors(Cyclin-dependent kinase (CDK) family inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndromes
Originator Organization
Senz Oncology Pty Ltd.
Active Organization-
Inactive Organization
Allyence Research Inc.Senz Oncology Pty Ltd.
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with VAL-1000
ACTRN12612000970842 / WithdrawnPhase 1/2
An exploratory Phase I/II safety and tolerability clinical evaluation of VAL-1000 in adults with Acute Leukaemias
100 Clinical Results associated with VAL-1000
Login to view more data
100 Translational Medicine associated with VAL-1000
Login to view more data
100 Patents (Medical) associated with VAL-1000
Login to view more data
100 Deals associated with VAL-1000
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Lymphoblastic LeukemiaPhase 2-
Senz Oncology Pty Ltd.
-
Acute Lymphoblastic LeukemiaPhase 2-
Allyence Research Inc.
-
Acute Lymphoblastic LeukemiaPhase 2
AU
--
Acute Myeloid LeukemiaPhase 2
AU
--
Acute Myeloid LeukemiaPhase 2-
Allyence Research Inc.
-
Acute Myeloid LeukemiaPhase 2-
Senz Oncology Pty Ltd.
-
Myelodysplastic SyndromesPhase 2
AU
--
Myelodysplastic SyndromesPhase 2-
Senz Oncology Pty Ltd.
-
Myelodysplastic SyndromesDiscovery-
Allyence Research Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free